ACT therapy
Selected indexed studies
- Cancer immunotherapies: advances and bottlenecks. (Front Immunol, 2023) [PMID:37691932]
- Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8(+) T-myeloid cell networks in melanoma. (Sci Immunol, 2024) [PMID:38306416]
- Challenges and new technologies in adoptive cell therapy. (J Hematol Oncol, 2023) [PMID:37596653]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy. (2022) pubmed
- Cancer immunotherapies: advances and bottlenecks. (2023) pubmed
- Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8(+) T-myeloid cell networks in melanoma. (2024) pubmed
- Challenges and new technologies in adoptive cell therapy. (2023) pubmed
- Emerging therapies in Ewing sarcoma. (2024) pubmed
- SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomics. (2025) pubmed
- Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review. (2023) pubmed
- Adoptive cellular therapy. (2011) pubmed
- Adoptive T cell therapy for ovarian cancer. (2024) pubmed
- The counterattack. (2024) pubmed